shutdown – Talk Bio

Oncolytics Biotech Provides Update on Special Meeting of Shareholders

3 weeks ago talkbio0Tagged biotech, Corporate, Government, jurisdiction, Nevada, Oncolytics, rescheduling, shareholders, shutdown, update

Oncolytics Biotech; special meeting; shareholders; rescheduling; government shutdown; jurisdiction change; Nevada; corporate update

Arena BioWorks Shuts Down After Investors Withdraw Support for Bold Biotech Model

1 month ago talkbio0Tagged Arena BioWorks, Biomedical Research, concerns, Funding, funding environment, Industry, investor, layoffs, Policy, shutdown, Uncertainty

Arena BioWorks; biotech shutdown; policy uncertainty; funding environment; biomedical research; $500 million funding; layoffs; biotech industry; investor concerns

Despite Government Shutdown, Companies Still Plan to Submit FDA Applications

2 months ago talkbio0Tagged AbbVie, amgen, Application procedure, biology (field), drug applications, funding lapse, Government, J&J, Myers Squibb, Pfizer, pharmaceutical delays, shutdown, United States Food and Drug Administration, user fees

FDA shutdown; new drug applications; biologic applications; user fees; pharmaceutical delays; government funding lapse; AbbVie; Amgen; Bristol Myers Squibb; J&J; Pfizer

Healthcare Sector Winners and Losers in the 2024 Government Funding Bill

12 months ago talkbio0Tagged Government, Health care facility, hospital-at-home programs, Legislation, Medicaid, Medicare, pay, Payments, Physicians, shutdown, Symmetrical dyschromatosis of extremities, Telemedicine

Healthcare funding, government shutdown, telehealth, Medicare payments, Medicaid DSH, hospital-at-home programs, physician pay cuts, healthcare legislation.

Theratechnologies Warns of Temporary Supply Disruption for EGRIFTA SV in Early 2025 Due to Third-Party Facility Shutdown

1 year ago talkbio0Tagged Disruption, Egrifta, Facility (object), HIV drug, shutdown, sievert, Theratechnologies

Theratechnologies, EGRIFTA SV, supply disruption, third-party facility shutdown, HIV drug, 2025